MDXG
MiMedx Group, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +2.8% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 90 | 0 | 52.34M | $201.56M | +8 | −8 |
| Q1 2026 | 93 | 0 | 53.34M | $210.99M | +4 | −4 |
| Q4 2025 | 93 | +1 | 51.21M | $346.71M | +1 | — |
| Q3 2025 | 19 | 0 | 33.28M | $232.30M | — | — |
| Q2 2025 | 16 | 0 | 31.16M | $190.41M | +1 | −1 |
| Q1 2025 | 13 | -1 | 11.80M | $89.67M | — | −1 |
| Q4 2024 | 14 | +1 | 11.42M | $109.89M | +1 | — |
| Q3 2024 | 12 | -2 | 7.09M | $41.90M | — | −2 |
| Q2 2024 | 14 | — | 7.86M | $54.46M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 11.53M | — | $70.42M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 2 | The Vanguard Group ✦ (passief) | 6.96M | — | $42.51M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passief) | 3.47M | +0.2% | $21.18M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 2.84M | -2.4% | $17.37M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 5 | Renaissance Technologies ✦ | 2.11M | +9.2% | $12.88M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 6 | Millennium Management ✦ | 1.67M | +35.9% | $10.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 791.78K | +30.5% | $4.84M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | Citadel Advisors ✦ | 452.67K | +1.5% | $2.77M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 9 | Marshall Wace ✦ | 379.16K | Nieuw | $2.32M | 0.0% | New | 1 | SEC ↗ ×2 |
| 10 | Wellington Management ✦ | 351.73K | -6.6% | $2.15M | 0.0% | ▼ Trim | 5 | SEC ↗ ×3 |
| 11 | Fisher Asset Management ✦ | 273.00K | 0.0% | $1.67M | 0.0% | Held | 5 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 102.88K | -68.3% | $628,609 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 98.96K | -2.3% | $604,664 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 79.30K | +54.9% | $486,000 | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 15 | AQR Capital Management ✦ | 33.94K | +136.1% | $207,355 | 0.0% | ▲ Add | 3 | SEC ↗ ×4 |
| 16 | Fidelity (FMR) ✦ | 25.90K | — | $158,264 | 0.0% | n/c | 1 | SEC ↗ ×2 |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Marshall Wace | $2.32M | 0.0% |
Verlaten
| Norges Bank | $535,040 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 234 houders, 112.82M aandelen, $439.18M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.